Clinical trial
The Study to Reevaluate the Safety and Efficacy of Human Urinary Kallikrein
NCT02562183 is registered in ClinicalTrials.gov with Techpool Bio-Pharma Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Study to Reevaluate the Safety and Efficacy of Human Urinary Kallikrein
- Lead sponsor
- Techpool Bio-Pharma Co., Ltd.
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- August 31, 2015
- Completion date
- November 30, 2018
- Enrollment
- 2,186 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.